Lysando in the News

Frankfurter Allgemeine Zeitung, 22.2.2018, german language

„The medical sensation“

There is hope for patients, in which the general-purpose drug no longer works: The start-up Lysando achieved great success with Artilysins. But a hurdle has not been overcome in the race against resistant bacteria ...

Lysando on TV

Artilysin®

Lysando

Decubitus

Feed

About us

LYSANDO AG is the world leading company for the development of antimicrobial proteins to combat Gram-positive and Gram-negative pathogens. In a wide range of fields including hygiene, agriculture, domestic and livestock husbandry, medical devices, veterinary and human pharma, LYSANDO AG provides a solution that is right for every customer.